Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-07-25 4:40 pm Unchanged | 13G | CARA THERAPEUTICS INC CARA | Vifor (International) Ltd | 7,396,770 13.7% | 0 (Unchanged) | View |
| 2023-07-07 09:17 am Purchase | 13G | ELICIO THERAPEUTICS INC ELTX | Vifor (International) Ltd | 199,564 0.02% | 199,564 (New Position) | View |
| 2022-03-30 3:51 pm Purchase | 13G | ANGION BIOMEDICA CORP COM ANGN | Vifor (International) Ltd | 1,995,643 6.7% | 1,995,643 (New Position) | View |
| 2021-10-21 4:15 pm Purchase | 13G | CARA THERAPEUTICS INC CARA | Vifor (International) Ltd | 7,396,770 13.9% | 3,282,391 (+79.78%) | View |
| 2021-10-13 6:54 pm Sale | 13D | CHEMOCENTRYX INC CCXI | Vifor (International) Ltd | 5,194,085 7.4% | -4,089,660 (-44.05%) | View |
| 2020-10-23 4:05 pm Purchase | 13G | CARA THERAPEUTICS INC CARA | Vifor (International) Ltd | 4,114,379 8.3% | 4,114,379 (New Position) | View |
| 2020-07-31 4:54 pm Sale | 13D | CHEMOCENTRYX INC CCXI | Vifor (International) Ltd | 9,283,745 13.7% | -693,378 (-6.95%) | View |
| 2020-07-16 07:56 am Sale | 13D | CHEMOCENTRYX INC CCXI | Vifor (International) Ltd | 9,977,123 14.7% | -699,702 (-6.55%) | View |